| |
|
|
|
|
|
|
|||
|
Blood, 15 September 2008, Vol. 112, No. 6, pp. 2278-2286. Prepublished online as a Blood First Edition Paper on June 19, 2008; DOI 10.1182/blood-2007-12-128751.
GENE THERAPY Resistance of mature T cells to oncogene transformation1 Georg-Speyer-Haus, Institute for Biomedical Research, Frankfurt; 2 University Hospital of the Johann Wolfgang Goethe-University, Experimental Pediatric Oncology and Hematology, Frankfurt am Main; 3 Hannover Medical School, Department of Experimental Hematology, Hannover; and 4 University of Frankfurt, Department of Pathology, Frankfurt, Germany
Leukemia caused by retroviral insertional mutagenesis after stem cell gene transfer has been reported in several experimental animals and in patients treated for X-linked severe combined immunodeficiency. Here, we analyzed whether gene transfer into mature T cells bears the same genotoxic risk. To address this issue in an experimental "worst case scenario," we transduced mature T cells and hematopoietic progenitor cells from C57BL/6 (Ly5.1) donor mice with high copy numbers of gamma retroviral vectors encoding the potent T-cell oncogenes LMO2, TCL1, or
Related Article in Blood Online:
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2008 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||